BMBengü Macit

Bengü Macit

*This is an algorithmically generated author record based on publicly available information.

Bengü Macit has a total of 7 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Renal Complications After Pediatric Hematopoietic Stem Cell Transplantation: A Retrospective Cohort Study

    by Bengü Macit, Arzu Akyay, Yurday Öncül, Yılmaz Tabel, Ahmet Taner Elmas

    Background/Objectives: Kidney-related complications contribute substantially to morbidity in children undergoing hematopoietic stem cell transplantation (HSCT), although evidence in pediatric populations remains limited. This study aimed to evaluate the incidence of acute kidney injury (AKI), chronic kidney disease (CKD), and hypertension within the first two years following HSCT and to investigate factors associated with these complications. Methods: We retrospectively analyzed 70 pediatric patients who underwent HSCT at the İnönü University Pediatric Bone Marrow Transplantation Unit between November 2017 and December 2023; patients who died during follow-up were excluded. Renal function was assessed using serum creatinine, the glomerular filtration rate was measured by 24-h urine collection or estimated using the Schwartz formula, and renal imaging was performed. The Acute Kidney Injury Network criteria were used to classify AKI, whereas CKD was defined according to the Kidney Disease Outcomes Quality Initiative criteria. Associations with demographic characteristics, primary disease, conditioning regimen, nephrotoxic drug exposure, graft-versus-host disease, veno-occlusive disease, and infections were evaluated. Results: AKI occurred in 54.3% of patients during the first 100 days, comprising stage 1 in 30.0%, stage 2 in 17.1%, and stage 3 in 7.1%. Primary diagnosis, conditioning regimen, nephrotoxic drug use, and transplantation-related complications were not significantly associated with AKI. Hypertension developed in 32.9% of patients, with most cases occurring during the early period after transplantation. A significant association was observed between hypertension and myeloablative conditioning without total body irradiation (p = 0.014). CKD was present in 45.7% of evaluated patients at month 6 and 44.6% at month 12. Amphotericin B use was significantly associated with CKD at month 6 (p = 0.015). No patient developed end-stage kidney disease or required dialysis. Conclusions: Renal complications were common after pediatric HSCT. AKI occurred frequently during the first 100 days, while CKD remained prevalent at 6 and 12 months. Younger age and amphotericin B exposure were associated with CKD in this cohort. Early recognition of renal injury and long-term kidney follow-up are warranted after pediatric HSCT.

  • Gaucher Disease Type 1, A Rare Disease: A Single Center-Experience

    by Fatma İ̇lknur Varol, Ayşe SELİMOĞLU, Şükrü Güngör, Bengü Maci̇t

    Aim: Gaucher disease is a rare lysosomal storage disease. Enzyme replacement therapy has proven to be very effective in reversing the risk of hepato-splenomegaly, cytopenia, osteopenia and reducing the risk of avasculer osteo necrosis, especially in children and young adults. The aim of this study is to draw attention to this rare disease and increase awareness. Material and Methods: All medical records of 8 patients diagnosed with Gaucher disease between 2008 and 2020 in our clinic were reviewed. Result: Five of the cases were female (62.5%), average age at diagnosis; was 7.9 years. When complaints at the time of admission are examined, we found that, 3 patients admitted with swelling in the abdomen, one admitted with abdominal pain, and 4 patients had been referred to our center due to organomegaly detected during the examination. In physical examination 8 patient had splenomegaly. The mean level of glucocerebrosidase enzyme of the patients was found to be 0.61mmol/l/h (normal range of glucocerebrosidase >3.2mmol/l/h). Considering the genetic analysis of the patients, 5 patients had homozygous and 3 patients had heterozygous mutations. One patient with portal hypertension who did not respond to enzyme replacement therapy at the time of admission underwent liver transplant. Conclusion: Early diagnosis and treatment are important to live with in mind that this disease, which is rare in societies where consanguineous marriage is common and can result in serious morbidity and early death, can be seen more frequently.